Similar articles

• Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.

  Carroll DS, Kemeny NE, Gralla RJ. Carroll DS, et al. Cancer Treat Rep. 1979 Jan;63(1):139-40. Cancer Treat Rep. 1979. PMID: 369686 Clinical Trial. No abstract available.
• Phase II evaluation of pyrazofurin in patients with carcinoma of the lung.

  Gralla RJ, Currie VE, Wittes RE, Golbey RB, Young CW. Gralla RJ, et al. Cancer Treat Rep. 1978 Mar;62(3):451-2. Cancer Treat Rep. 1978. PMID: 348315 Clinical Trial. No abstract available.
• Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.

  Nichols WC, Kvols LK, Ingle JN, Edmonson JH, Ahmann DL, Rubin J, O'Connell MJ. Nichols WC, et al. Cancer Treat Rep. 1978 May;62(5):837-9. Cancer Treat Rep. 1978. PMID: 657166 Clinical Trial.
• [Chemotherapy and immunochemotherapy in colorectal neoplasms].

  Nishi M, Uehara H, Ishizawa T, Kuwahara D, Yoshii H, Yotsumoto K, Aiko T. Nishi M, et al. Nihon Rinsho. 1981 May;39(5):2180-7. Nihon Rinsho. 1981. PMID: 7026835 Review. Japanese. No abstract available.
• Ascorbic acid does not cure cancer.

  [No authors listed] [No authors listed] Nutr Rev. 1985 May;43(5):146-7. doi: 10.1111/j.1753-4887.1985.tb06894.x. Nutr Rev. 1985. PMID: 3897919 Review. No abstract available.